Literature DB >> 10692613

Nociceptive and inflammatory effects of subcutaneous TNFalpha.

H Junger1, L S Sorkin.   

Abstract

Tumor necrosis factor alpha (TNF) is a potent pro-inflammatory cytokine that produces pain and hyperalgesia following injection. Its algesic effects are due to sensitizing actions on nociceptive primary afferents and to the upregulation of other pro-inflammatory and algesic proteins. In anesthetized rats, we investigated the effect of subcutaneously injected TNF on background activity and mechanical sensitivity of C nociceptors of the sural nerve, as well as its effects on cutaneous plasma extravasation. TNF sensitized C nociceptors dose-dependently; the optimal dose (5 ng) lowered threshold in 66.7% of the tested fibers. This sensitization occurred within 30 min and could last for 2 or more hours. Injected TNF had no effect on Abeta mechanoreceptive fibers. In addition, TNF evoked ongoing activity in 14% of C nociceptors and caused significant and dose-related increases in vascular permeability in glabrous skin. Our data suggest that TNF released during disease or after tissue injury participates in the generation of hyperalgesia and inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692613     DOI: 10.1016/s0304-3959(99)00262-6

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  65 in total

1.  A p38 mitogen-activated protein kinase-dependent mechanism of disinhibition in spinal synaptic transmission induced by tumor necrosis factor-alpha.

Authors:  Haijun Zhang; Hui Nei; Patrick M Dougherty
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

2.  Cytokine expression in the epidural space: a model of noncompressive disc herniation-induced inflammation.

Authors:  Jason M Cuéllar; Paula M Borges; Vanessa Gabrovsky Cuéllar; Andrew Yoo; Gaetano J Scuderi; David C Yeomans
Journal:  Spine (Phila Pa 1976)       Date:  2013-01-01       Impact factor: 3.468

3.  Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha.

Authors:  Xiaochun Jin; Robert W Gereau
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

4.  Severe pain during wound care procedures: A cross-sectional study protocol.

Authors:  Catherine A Fiala; Linda I Abbott; Cheryl D Carter; Stephen L Hillis; Jessica S Wolf; Meghan Schuster; Rachel Dulski; Elizabeth A Grice; Barbara A Rakel; Sue E Gardner
Journal:  J Adv Nurs       Date:  2018-05-07       Impact factor: 3.187

Review 5.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 6.  Mode of action of cytokines on nociceptive neurons.

Authors:  Nurcan Uçeyler; Maria Schäfers; Claudia Sommer
Journal:  Exp Brain Res       Date:  2009-03-17       Impact factor: 1.972

7.  Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.

Authors:  Liting Deng; Josée Guindon; Benjamin L Cornett; Alexandros Makriyannis; Ken Mackie; Andrea G Hohmann
Journal:  Biol Psychiatry       Date:  2014-04-25       Impact factor: 13.382

Review 8.  A brief comparison of the pathophysiology of inflammatory versus neuropathic pain.

Authors:  Qinghao Xu; Tony L Yaksh
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

9.  A peripheral neuroimmune link: glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-alpha, and RANTES in cultured human synoviocytes.

Authors:  Terry A McNearney; Yinghong Ma; Yueping Chen; Giulio Taglialatela; Huaizhi Yin; Wen-Ru Zhang; Karin N Westlund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-09       Impact factor: 3.619

10.  Significance of Conversation between Mast Cells and Nerves.

Authors:  Hanneke Pm van der Kleij; John Bienenstock
Journal:  Allergy Asthma Clin Immunol       Date:  2005-06-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.